July 2, 2017



Recombinant Human Growth Hormone (rDNA origin) USP (10 vials x 12IU)

 76.5mg/ml Solution tor injection

Read this entire leaflet carefully before you use this medicine.

Each ml contains:

Trenbolone Hexahydrobenzylcarbonate 76.5mg Oil base q.s.
Indicationsand usage:

Hetroxyl 76.5** is an oil based solution of trenbolone hexahydrobenzylcarbonate for IM injection. Trenbolone is an anabolic steroid with significant anabolic and androgenic elfects.

On administration of Hetroxyl 76.5″* there is an increase m muscle hardness, muscular strength in combination with a protein rich diet. Trenbolone speeds up the metabolism and acceierales the burning of adipose tissue. The high androgenic effeci prevents a possible muscle break down syndrome and accelerates the regeneration of muscle tissue.


Hetroxyl 76 S’* contraindicated m kidney dysfunction, hypertension, cardiac patients. Also its contraindicated in infants, pregnancy and nursing mothers. Hetroxyl 76.5** should not be used in patients with: knownhypersensitrvity to any ingredients m this product known or suspected carcinomas of the breast, testis, or prostate.

Severe heart disease, liver disease, a history of epilepsy.

Products containing androgens should not be used in women as they may cause virilization and fatal harm.

Drug interactions:

Patients on oral anticoagulant therapy require close monitoring especially when androgens are started or slopped.

Diabetics: androgens may alter the metabolism of oral hypogtyceme agents or may change insulin sensitivity in patients with diabetes meliitus which may require adjustment of dosageolinsuimand other hypogiycemicdrugs.

May altar metabof $m of cyclosporins Avoid other hepatotoxicmedications.


There have been no reports of acute overdosage with the anaboi <$.

Side effects / Adverse reactions:

Male: Gynecomastia, excessive frequency and duration of penile erections, oligospermia.

Hirsutism, mate pattern baldness and acne, gynecomastia.

Retention of sodium, chloride, wafer, potassium, calcium, and inorganic phosphates.

Nausea, cholestatic jaundice, alterations in liver function tests: hepatocellular neoplasms, peliosis hepatitis, hepatic adenomas, nephniis, and cholestatic hepatitis.

increased idido, headache, anxiety, depression, extreme agitation, notability, and generalized paresthesia. Trenbolone may cause severe aggressive behaviour.

Other Serum lipid changes. hypertension. hypercaicaenva, hypertension, oedema, priapism

Precautions / Warnings:

Trenbolone should be used with extreme caution and with the lowest dosage and duration of treatment necessary for cSnical response pursuant to the advice ofaqualified physician.

Because andiogens may alter serum cholesterol concentration, caution should be used when administering these drugs to patients wdh a history of myocardial i nfarclion or coronary artery disease.

Trenbolone may increase aggressiveness and cause psychiatric changes. At the first sign of psychiatric changes discontinue use ofirenboione and contact a physician.

Due to its hepaiotoxcity. liver functions should be monitored. Discontinue on signs of jaundicing

When administered parentally there is tightness in the chest and a metallic taste in the back of the mouth, followed by an uncontrollable violent cough & bronchoconstncion. Trenbolone reduces endogenous T3 thyriod levels and increases protection levels. Thus to overcome the unwanted side effects that could be caused by rise in prolactin levels. T3 should be used throughout a trenbolone treatment.

Women, children and elderly males should not use Hetroxyl 76.5’*
Dosage and adminstration:

Hetroxyl 76 5** is Trenbolone Hexahydrobenzylcarbonate. it is a long-8Cting variant of Trenbolone with an active life of 5-7 days. With this being the case. Hetroxyl 76.5’* doses are best administered twice weekly. Hetroxyl 76.5** doses normally land in the range of 153 -306mg per week.

Female Dosage

Hetroxyl 76.5’* is not recommended for females How supplied

Hetroxyl 76.5″ is supplied in I ml ampoule. Ampoules should be stored at controlled room temperatures below 30*C and protected from light.

Parenteral drug products should be inspected visually for particulate matter and declaration prior to administration, whenever solution and container permit. Warming and shaking the ampoules should redissolve any crystals that may have formed during storage at temperatures lower than recommended, n it has expired or t$ damaged, return it to your pharmacist for disposal.

Abuse in Sports

Abuse of this product in sports i$ highly discouraged. Tha>ger pharma does not take any responsibility for use of this produd for any other purpose. This product should be used under proper medical supervision.

Keep out of the reach and sight of children.

Effect of materials on plants or animals: This product may be harmful lo contaminated ptani and animal life.

Effect of chemicals on aquatic life: This product may be harmlul lo aquatic plant and anuneJ life m contaminated bodies of water, especially if released m large quantities

Reviews (0)


There are no reviews yet.

Be the first to review “GERIOSTIM”

Your email address will not be published. Required fields are marked *